BW Communities

author-image

C H Unnikrishnan

Author

Unnikrishnan is currently Senior Associate Editor with BW Businessworld at its Mumbai Bureau. During his two decades long journalistic career, he has received several media awards and recognitions. His articles on healthcare, life sciences and intellectual property rights (IPR) have been republished by several international blogs and journals. 

Latest Articles By C H Unnikrishnan

Mockery Of Corporate Governance: The Sun Pharma Way

Sun Pharma has not only violated the good corporate governance in terms of transparency but also consciously tried to make the investors believe that there is no plan to either divest assets or to cut jobs by strongly denying the then true media reports

Read More
Infrastructure: Hubs Of Good Hope

The new generation ports could breathe life into the backwaters, morphing remote hamlets into economic hotspots

Read More
Probe Brings Warring Partners Closer

The $75-million settlement from USL to former chairman Mallya for stepping down from the post was announced in February

Read More
Sun Pharma Q4 Net Up 93 Per Cent On Exclusivity Sales In US, Low cost

Sun Pharma’s formulation sales in the United States at $580 million during the quarter grew 19 per cent over the last year

Read More
India Approves First Stem Cell-based Drug For Buerger's Disease

The drug controller general of India has granted limited approval to Stempeutics Research, a joint venture between drug maker Cipla and Manipal Group for manufacturing and marketing its stem cell based biological drug Stempeucel for the treatment of Buerger’s Disease

Read More
FedEx Acquires TNT Express For $4.4 Billion

Together, FedEx and TNT Express will continue to make a difference in the lives of people around the world, further supporting the communities in which team members live and work, connecting even more people and possibilities

Read More
Dr Reddy's Acquires 6 OTC Brands From Ducere Of US

Dr Reddy's Laboratories said on Wednesday that it has acquired a range of consumer health or over-the-counter brands from the US-based Ducere Pharma Llc for an undisclosed sum

Read More
Analysts Cut Cipla 2017 Estimate After Weak Q4 Show

Cipla’s January-to-March quarter results were below the market expectation due to inventory write-offs or reductions, rationalisation of unviable geographies, higher research and development spends and regulatory costs

Read More
‘Our Quality Kept Us Alive’

Gautam Singhania, Chairman and managing director, Raymond, spoke to BW Businessworld about textile industry and its secret of survival

Read More
Making ‘The Complete Man’ And More

Raymond, a perfect guide to a well-dressed man, will soon be one to women too, with more brands up its sleeve

Read More

Subscribe to our newsletter to get updates on our latest news